As COVID-19 vaccinations begin, dermatologists must be aware of the cutaneous adverse
events reported in the clinical trials, including injection site and hypersensitivity reactions …

Background COVID‐19 vaccines are currently the most effective interventions in controlling
and preventing severe disease progression. Dermatologic reactions to COVID‐19 …

As of April 22, 2021, the novel coronavirus disease 2019 (COVID-19) has sickened more
than 142 million people and taken more than 3 million lives worldwide. 1 Although …

Importance In response to the coronavirus disease 2019 (COVID-19) pandemic, 2 mRNA
vaccines (Pfizer-BioNTech and Moderna) received emergency use authorization from the …

Although vaccination is widely accepted as an effective method of preventing and controlling
the COVID‐19 pandemic, many people are concerned about possible cutaneous side …

To the Editor: We thank the authors for their reply to our article and would like to clarify the
concerns described. 1 The letter noted that the distribution of COVID-19 vaccine skin …

Despite the growing availability of coronavirus disease 2019 (COVID-19) vaccines in the
general population, a significant proportion of individuals demonstrate vaccine hesitancy …

Numerous vaccines are under clinical development and implementation for the prevention
of severe course and lethal outcomes of coronavirus disease 2019 (COVID‐19). This …

Considering the emergency approval of the Food and Drug Administration for widespread
use of coronavirus disease 2019 (COVID‐19) vaccines, evaluating potential vaccine‐related …

The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide
challenge, strongly impacting on the global economy, overall health and lifestyle. Since …